Search filters

List of works by James Lewis Abbruzzese

5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer

scientific article published in June 2005

A Novel, Clinically Relevant Animal Model of Metastatic Pancreatic Adenocarcinoma Biology and Therapy

scientific article published on January 1, 2001

A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study

scientific article published on 01 November 2006

A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis

scientific article published on March 2003

A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer

scientific article

A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors

scientific article published on May 1, 2012

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

scientific article published on 27 May 2008

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer

scientific article published on 27 January 2010

ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer

scientific article published on 15 August 2015

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

scientific article published on June 13, 2011

AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells

scientific article

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation

scientific article published on January 2005

Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma

scientific article published on 17 January 2014

Adjuvant therapy for pancreatic cancer: current status and future directions

scientific article published in October 2004

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells

scientific article published in April 2006

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals

scientific article published on February 12, 2011

Association between hepatitis B virus and pancreatic cancer

scientific article

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States

scientific article published on May 2009

Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer

scientific article published on 6 May 2011

Association of diabetes and perineural invasion in pancreatic cancer.

scientific article published on 30 October 2012

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

scientific article

Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome

scientific article published on October 4, 2010

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

scientific article published on 09 April 2011

Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer

scientific article published on February 25, 2011

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer

scientific article

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

scientific article published on 24 July 2006

Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells

scientific article published on December 2005

Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis

scientific article published on December 2005

Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.

scientific article

Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

scientific article published on 01 June 2008

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

scientific article published in March 2004

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

scientific article

Chemotherapy and radiation of anal canal cancer: the first approach

scientific article published on April 2004

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma

scientific article

Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma

scientific article

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

scientific article published on 24 October 2006

Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells

scientific article published on 12 May 2015

Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions

scientific article published on January 2006

DNA Mismatch Repair Gene Polymorphisms Affect Survival in Pancreatic Cancer

scientific article published on January 6, 2011

DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer

scientific article published on June 16, 2011

DNA repair gene polymorphisms and risk of pancreatic cancer

scientific article published on January 2009

Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells

scientific article published on January 22, 2013

Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?

scientific article published on 01 March 2007

Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma

scientific article

Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer

scientific article

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.

scientific article published on May 2017

Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.

scientific article published in January 2005

Diagnostic protein discovery using proteolytic peptide targeting and identification

scientific article

Diagnostic strategies for unknown primary cancer

scientific article published on May 2004

Dietary mutagen exposure and risk of pancreatic cancer

scientific article published in April 2007

Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution

scientific article published on 16 June 2007

Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients

scientific article published on September 2006

Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery

scientific article published in May 2005

Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model

scientific article published in May 2005

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

scientific article published on 01 October 2006

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study

scientific article published on October 2008

Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

scientific article published on December 2008

Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer

scientific article published on 08 November 2011

Effects of base excision repair gene polymorphisms on pancreatic cancer survival

scientific article published in April 2007

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

scientific article

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer

scientific article published on 01 April 2011

Experimental animal models of pancreatic carcinogenesis and metastasis

scientific article

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

scientific article

Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma

scientific article published on July 2015

Function of nuclear factor kappaB in pancreatic cancer metastasis

scientific article published on January 2003

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

scientific article

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

scientific article

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction

scientific article published on 15 June 2013

Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer

scientific article published on March 16, 2011

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer

scientific article published on September 15, 2010

Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer

scientific article published in March 2007

High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma

scientific article published on 13 July 2010

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

scientific article published on October 25, 2011

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation

scientific article published on December 16, 2011

I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score

scientific article published on August 3, 2011

Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer

scientific article

In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer

article

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

scientific article published on 01 July 2007

Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice

scientific article

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model

scientific article

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis

scientific article published on March 2003

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

scientific article

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer

scientific article

Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer

scientific article published on August 17, 2011

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer

scientific article

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival

scientific article

Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.

scientific article

Introducing new strategies in...

scientific article published on 23 February 2010

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

scientific article published in April 2002

K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking

scientific article

LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

scientific article

Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk

scientific article published in August 2007

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma

scientific article

Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma

scientific article published on December 20, 2012

Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death

scientific article published on May 2007

Metastatic patterns in adenocarcinoma

scientific article published in April 2006

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

scientific article

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

scientific article published on 02 July 2013

Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification

scientific article published on 16 October 2013

Multimodality Therapy Offers a Chance for Cure in Patients with Pancreatic Adenocarcinoma Deemed Unresectable at First Operative Exploration

scientific article published on May 18, 2012

NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells

scientific article published in January 2004

New option for the initial management of metastatic pancreatic cancer?

scientific article

New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts

scientific article

Novel therapies for pancreatic adenocarcinoma

scientific article published on May 2004

Novel therapies for pancreatic adenocarcinoma

scientific article

Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin

scientific article (publication date: 15 June 2005)

Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS

Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet

scientific article published on 25 July 2019

Opportunities for targeted therapies in hepatocellular carcinoma

scientific article

Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

scientific article published on June 4, 2012

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

scientific article published on October 4, 2010

Overexpression of synuclein-gamma in pancreatic adenocarcinoma

scientific article published on July 2004

Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.

scientific article

Pancreatic cancer mortality in Egypt: comparison to the United States pancreatic cancer mortality rates

scientific article published on 25 October 2006

Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma

scientific article published on 20 September 2013

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study

scientific article

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis

scientific article

Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation

scientific article

Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

scientific article published on March 1, 2012

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

scientific article

Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

scientific article

Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors

scientific article

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

scientific article published on December 2002

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer

scientific article published in March 2006

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

scientific article published on August 2004

Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer

scientific article published on April 1, 2003

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

scientific article published on June 27, 2011

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma

scientific article

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

scientific article published on 24 April 2006

Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma

scientific article

Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy

scientific article published on January 2002

Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer

scientific article published on 01 October 2002

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

scientific article published on 01 May 2006

Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers

scientific article

Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins

scientific article published in February 2005

Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes

scientific article published on 8 December 2006

Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation

scientific article published on July 6, 2011

Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I

scientific article published on 01 July 2002

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

scientific article published on 24 October 2016

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

scientific article

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

scientific article published in July 2008

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

scientific article

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

scientific article published on 01 December 2006

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma

scientific article published on 19 September 2013

Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases

scientific article published on 30 March 2007

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

scientific article

Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer

scientific article published on 13 January 2009

Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry

scientific article

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.

scientific article published on 5 November 2015

Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas

scientific article published in June 2005

Reassessing hepatocellular carcinoma staging in a changing patient population

scientific article

Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells

scientific article published on April 2007

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

scientific article published on 17 May 2012

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

scientific article

Risk factors for pancreatic cancer: case-control study

scientific article

SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms

scientific article published on 19 October 2013

Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.

scientific article

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer

scientific article published in April 2017

Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation

scientific article

Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer.

scientific article

Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer

scientific article published on 23 February 2009

Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival

scientific article

Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.

scientific article

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer

scientific article

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity

scientific article

Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer

scientific article

Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells

scientific article published on November 8, 2012

Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution

scientific article published on 01 February 2014

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

scientific article published on 15 March 2018

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

scientific article published on 01 January 2003

Stemming the tide of hepatitis B virus related hepatocellular carcinoma?

scientific article published in January 2008

Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant

scientific article published on 13 June 2005

Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells

scientific article published on 01 November 2002

Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells

scientific article published on November 2006

Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway.

scientific article published in January 2008

Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway

scientific article published on April 2008

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models

scientific article published on 01 July 2007

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial

scientific article published in February 2005

The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1

scientific article

The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

scientific article published on 01 May 2018

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells

scientific article

The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk

scientific article published on 3 February 2006

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer

scientific article published on 04 May 2013

The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States

scientific article

The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy

scientific article

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation

scientific article

The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells

scientific article published on 13 June 2005

The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis

scientific article

Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells

scientific article

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

scientific article published on 3 March 2009

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines

scientific article published on April 2006

Transport properties of pancreatic cancer describe gemcitabine delivery and response

scientific article published on 10 March 2014

Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival

scientific article published on 16 November 2013

Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy

scientific article published on April 1, 2012

Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt

scientific article published on January 2002

Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?

scientific article published on November 5, 2012

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

scientific article

XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer

scientific article